Sirolimus-eluting stents remain superior to bare-metal stents at two years: Medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry

Journal of the American College of Cardiology

Volumn 47, Issue 7, 2006, Pages 1356-1360

  Ong, Andrew T L ^a   Van Domburg, Ron T ^a   Aoki, Jiro ^a   Sonnenschein, Karel ^a   Lemos, Pedro A ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METAL IMPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; VASCULAR LESION;

AGED; CORONARY ARTERIOSCLEROSIS; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETREATMENT; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 33645416316     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.05.102     Document Type: Article

References (15)

1. Stories of Survival and Hope Mark the One Million Patient Milestone for the Cypher Sirolimus-Eluting Coronary Stent 2005 February 14, Available at: http://www.jnj.com/news/jnj_news/20050214_094141.htm. Accessed February 16, 2005
2. J.E. Sousa, M.A. Costa, A.G. Sousa Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries Circulation 107 2003 381 383
3. M. Degertekin, P.W. Serruys, D.P. Foley Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up Circulation 106 2002 1610 1613
4. J. Fajadet, M.C. Morice, C. Bode Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents three-year results of the RAVEL trial Circulation 111 2005 1040 1044
5. A.J. Carter, M. Aggarwal, G.A. Kopia Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model Cardiovasc Res 63 2004 617 624
6. I.P. Kay, A.J. Wardeh, K. Kozuma Radioactive stents delay but do not prevent in-stent neointimal hyperplasia Circulation 103 2001 14 17
7. R. Virmani, G. Guagliumi, A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious? Circulation 109 2004 701 705
8. E.P. McFadden, E. Stabile, E. Regar Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521
9. P.A. Lemos, P.W. Serruys, R.T. van Domburg Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world" the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry Circulation 109 2004 190 195
10. P.A. Lemos, C.H. Lee, M. Degertekin Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes insights from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry J Am Coll Cardiol 41 2003 2093 2099
11. S.C. Smith Jr, J.T. Dove, A.K. Jacobs Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 37 2001 2239i-lxvi
12. M.N. Babapulle, L. Joseph, P. Belisle, J.M. Brophy, M.J. Eisenberg A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet 364 2004 583 591
13. M.C. Morice, P.W. Serruys, J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
14. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis a randomized controlled trial JAMA 291 2004 1071 1080
15. A.T. Ong, E.P. Mc Fadden, E. Regar, P.P. de Jaegere, R.T. van Domburg, P.W. Serruys Late angiographic stent thrombosis (LAST) events with drug-eluting stents J Am Coll Cardiol 45 2005 2088 2092